<DOC>
	<DOCNO>NCT02859220</DOCNO>
	<brief_summary>This study include 80 patient end stage renal disease require dialysis treatment evaluate two technique determination parathyroid hormone ( PTH ) Objective : To evaluate whether monitor hemodialysis patient measurement PTH 1-84 Complete ( CAP =cyclase activate PTH ) ratio ( 1-84 PTH ( CAP ) /7-84 PTH ( CIP = cyclase inactivate PTH ) kit `` Duo PTH Immunoradiometric Scantibodies '' allow improvement therapeutic management abnormal calcium phosphate , good match target current international recommendation , follow conventional intact PTH assay . Primary endpoint : For patient , score award base number criterion ( include calcium , phosphorus calcium phosphate product ) target international guideline :0-1-2 3 . The primary endpoint average score group begin end study , Main secondary endpoint : - Changes number patient respond international guideline three parameter study ( serum phosphate , correct calcium , phosphorus product ) 2 group , - Evolution Elecsys intact PTH Roche 2 group , - Salaries change number drug normalize phospho-calcium balance group receive , - cardiovascular event ( morbidity cardiovascular mortality ) , - Total mortality . Statistical analysis : This randomize , two parallel arm . The investigator compare average number criterion calcium phosphate target accord Mann-Whitney . The analysis perform software Splus .</brief_summary>
	<brief_title>Study Influence Dosages 1-84 7-84 Fragments Parathyroid Hormone Compared Conventional Dosage Balance Calcium Phosphate Hemodialysis ( PTH )</brief_title>
	<detailed_description />
	<mesh_term>Polystyrene sulfonic acid</mesh_term>
	<criteria>replacement therapy hemodialysis least three month hemodialysis center Nantes University Hospital , intact PTH â‰¥ 100 pg / mL visit inclusion . intact PTH &lt; 100 pg / mL visit inclusion Life expectancy estimate less one year time inclusion , disease diagnose prior initiation study , bone pathology diagnose prior initiation study interfere calcium phosphate metabolism ( myeloma , Paget ... ) .</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2011</verification_date>
	<keyword>hemodialysis</keyword>
	<keyword>PTH</keyword>
</DOC>